Table II.

The baseline demographic and outcome measures for the 32 subjects prior to upper extremity robotic treatment.

Variables
Gender, male, %	72
Age, year, mean (SD) [median] (range)	56.0 (12.4) [57] (35–85)
Ethnicity, %
White	56
Black	28
other	16
Handedness, right, %	88
Time post-stroke, years, mean (SD) [median] (range)	4.1 (4.5) [2.5] (0.8–25.2)
Side of hemiparesis, right, %	50
Type of stroke, non-hemorrhagic, %	69
Lesion location, cortical (n = 30), %	60
Scales, mean (SD) [median] (range)
NIHSS	4.1 (2.1) [4.0] (1–10)
BDI	11.8 (6.9) [11.5] (1–31)
AMAT-9	1.22 (0.54) [1.13] (0.5–2.35)
ARAT	11.3 (10.3) [7.5] (0–38)
FMA (upper extremity)	22.0 (10.8) [20.0] (9–44)
WMFT	1.72 (0.74) [1.60] (0.4–3.13)
SIS – Hand	15.3 (21.6) [5.0] (0–80)
SIS – Comm	85.6 (15.8) [92.9] (54–100)

NIHSS: National Institutes of Health Stroke Scale score; BDI: Beck’s Depression Inventory; AMAT-9: Arm Motor Ability Test (9 item version); ARAT: Arm Research Action Test; FMA: Fugl Meyer Assessment -upper extremity; WMFT: Wolf Motor Function Test; SIS-Hand: Stroke Impact Scale Hand Function subscore; SIS-Comm: Stroke Impact Scale – communication subscore.